Nascent Biotech Inc (NBIO)
0.0899
+0.01
(+8.57%)
USD |
OTCM |
Jun 21, 16:00
Nascent Biotech Total Liabilities (Quarterly): 0.6109M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6109M |
| September 30, 2023 | 1.049M |
| June 30, 2023 | 1.234M |
| March 31, 2023 | 1.551M |
| December 31, 2022 | 1.930M |
| September 30, 2022 | 2.389M |
| June 30, 2022 | 1.620M |
| March 31, 2022 | 0.7769M |
| December 31, 2021 | 1.200M |
| September 30, 2021 | 1.151M |
| June 30, 2021 | 1.110M |
| March 31, 2021 | 1.224M |
| December 31, 2020 | 1.305M |
| Date | Value |
|---|---|
| September 30, 2020 | 0.9102M |
| June 30, 2020 | 1.398M |
| March 31, 2020 | 2.879M |
| December 31, 2019 | 0.9543M |
| September 30, 2019 | 0.8066M |
| June 30, 2019 | 0.6259M |
| March 31, 2019 | 0.6136M |
| December 31, 2018 | 0.5946M |
| September 30, 2018 | 0.5008M |
| June 30, 2018 | 10.77M |
| March 31, 2018 | 0.2034M |
| December 31, 2017 | 0.1571M |
| March 31, 2017 | 0.166M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6109M
Minimum
Dec 2023
2.879M
Maximum
Mar 2020
1.301M
Average
1.200M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.6413M |
| Shareholders Equity (Quarterly) | 0.0304M |